Artículos de revistas
Antiphospholipid Antibodies In Gestational And Pregestational Diabetic Women [prevalência De Anticorpos Antifosfolípides Em Diabéticas Gestacionais E Pré-gestacionais]
Registro en:
Revista Brasileira De Ginecologia E Obstetricia. , v. 28, n. 3, p. 179 - 183, 2006.
1007203
2-s2.0-33748905318
Autor
Rehder P.M.
Pereira B.G.
Couto E.C.
Amaral E.
Parpinelli M.A.
Institución
Resumen
Purpose: to diagnose and treat diabetic pregnant women with antiphospholipid antibodies and to describe the gestational and perinatal results. Methods: we evaluated 56 gestational and pregestational diabetic women who were attended at one specialized prenatal care unit, between July 2003 and March 2004. All of them had a blood test to quantify antiphospholipid antibodies. If positive, they were treated with heparin and aspirin at low doses and the usual treatment for diabetes. We calculated the prevalence and 95% confidence interval for all and also those for the pregestational ones. The characteristics of the pregnancies and the newborns are described. Results: antiphospholipid antibodies prevalence among the diabetic pregnant women was 7% (95% CI - 0.1 to 13.9). Among pregestational diabetic women it was 12% (95% CI - 0.2 to 23.3). Among the diabetic women with antiphospholipid antibodies the duration of disease was five years or more. Maternal age in positive antiphospholipid antibodies diabetics ranged from 27 to 38 years; one was primiparous, another was secundiparous and two were multiparous. Conclusion: antiphospholipid antibodies prevalence in diabetic pregnant women was similar to that in the general population and lower than that of the pregestational diabetic women. 28 3 179 183 Dias, E.P., Consenso sobre diabetes gestacional (1999) Arq Bras Endocrinol Metab, 43 (2), pp. 148-149 Diagnosis and classification of diabetes mellitus (2005) Diabetes Care, 28 (1 SUPPL.), pp. S37-42 Jensen, D.M., Damm, P., Moelsted-Pederson, L., Ovesen, P., Westergaard, J.G., Moeller, M., Outcomes in type 1 diabetic pregnancies: A nationwide, population-based study (2004) Diabetes Care, 27 (12), pp. 2819-2823 Lepercq, J., Taupin, P., Dubois-Laforque, D., Duranteau, L., Lahlou, N., Boitard, C., Heterogeneity of fetal growth in type 1 diabetic pregnancy (2001) Diabetes Metab, 27 (3), pp. 339-344 Sweeney, A.T., Brown, F.M., Gestational diabetes mellitus (2001) Clin Lab Med, 21 (1), pp. 173-192 Vaarasmaki, M., Anttila, M., Pirttiaho, H., Hartikainen, A.L., Are recurrent pregnancies a risk in type 1 diabetes? (2002) Acta Obstet Gynecol Scand, 81 (12), pp. 1110-1115 Clausen, T.D., Mathiesen, E., Ekbom, P., Hellmuth, E., Mandrup-Poulsen, T., Damm, P., Poor pregnancy outcome in women with type 2 diabetes (2005) Diabetes Care, 28 (2), pp. 323-328 Sibai, B.M., Caritis, S., Hauth, J., Lindheimer, M., VanDoorsten, J.P., MacPherson, C., Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus (2000) Am J Obstet Gynecol, 182 (2), pp. 364-369. , National Institute of Child Heath and Human Development Network of Maternal-Fetal Medicine Units Vaarasmaki, M., Gissler, M., Ritvanen, A., Hartikainen, A.L., Congenital anomalies and first life year surveillance in type 1 diabetic births (2002) Diabet Med, 19 (7), pp. 589-593 Palomo, I.G., Mujica, V.E., Alarcon, M.L., Pereira, J.G., Vasquez, M.R., Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals (2005) J Diabetes Complications, 19 (3), pp. 133-137 Boddi, M., Prisco, D., Fedi, S., Cellai, A.P., Liotta, A.A., Parretti, E., Antiphospholipid antibodies and pregnancy disorders in women with insulin-dependent diabetes (1996) Thromb Res, 82 (3), pp. 207-216 Lockshin, M.D., Qamar, T., Levy, R.A., Anticardiolipin and related antibodies: Thrombosis and fetal death (1990) Pregnancy, Autoimmunity and Connective Disorders, pp. 185-211. , Scott JS, Bird HA, editors. New York: Oxford University Press Wilson, W.A., Gharavi, A.E., Piette, J.C., International classification criteria for antiphospholipid syndrome: Synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium (2001) Lupus, 10 (7), pp. 457-460 Triplett, D.A., Obstetrical complications associated with antiphospholipid antibodies (1992) Immunological Obstetrics, pp. 377-403. , Coulam CB, Faulk WP, McITyre JA, editors. London: Norton Medical Books Galtier-Dereure, F., Biron, C., Vies, M., Bourgeois, V., Schved, J.F., Bringer, J., Vascular complications of diabetes mellitus: What role for phospholipid-binding antibodies? (1998) Lupus, 7 (7), pp. 469-474 Uszynski, M., Uszynski, W., Antiphospholipid syndrome in obstetrics-a new version of criteria, pathomechanism and the prophylaxis (2002) Ginekol Pol, 73 (6), pp. 553-566 Kdous, M., Hachicha, R., Lombroso, R., Gallardo, G., Antiphospholipid antibodies and pregnancy (2005) Tunis Med, 83 (1), pp. 1-5 Best, I.M., Anyadike, N.C., Bumpers, H.L., The antiphospholipid syndrome in a teenager with miscariages, thromboses, and diabetes mellitus (2000) Am Surg, 66 (8), pp. 748-750 Venkat-Raman, N., Backos, M., Teoh, T.G., Lo, W.T., Regan, L., Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome (2001) Obstet Gynecol, 98 (2), pp. 235-242 Huong, Dl., Wechsler, B., Bletry, O., Vauthier-Brouzes, D., Lefebvre, G., Piette, J.C., A study of 75 pregnancies in patients with antiphospholipid syndrome (2001) J Rheumatol, 28 (9), pp. 2025-2030 Nash, M.J., Camilleri, R.S., Liesner, R., Mackie, L.J., Machin, S.J., Cohen, H., Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodies (2003) Br J Haematol, 120 (3), pp. 529-531 Giusti, C., Are phospholipid-binding antibodies implicated in the pathogenesis of diabetic microangiopathy? (2004) Med Hypotheses, 63 (2), pp. 235-238 Noble, L.S., Kutteh, W.H., Lashey, N., Franklin, R.D., Herrada, J., Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin (2005) Fertil Steril, 83 (3), pp. 684-690